1-855-378-42281-855-378-4228
One of the outpatient rehab alternatives for people in Sharon Hill who are struggling with opioid dependence and addiction is called opioid maintenance therapy. Licensed centers and doctors are certified to give specific meds to opioid addicted clients, many of which are opioids themselves and are habit forming. With low amounts the user does not experience being high and also doesn't experience intense cravings and isn't experiencing opioid withdrawal. Methadone is the first drug administered for this purpose, but there are alternative options currently to pick from.
Methadone is an opioid and is meant to be taken at an outpatient clinic licensed to administer the drug, which is taken on a daily basis in liquid or pill form. The price of the drug is approximately one hundred and fifty dolloars a month. Buprenorphine is also an opioid based med, and is in pill form often taken one day on, one day off. But different from Methadone that is only be dispensed in highly structured clinics, Buprenorphine can be prescribed and administered in doctor's offices. The cost monthly of buprenorphine is about $300 a month for the generic of the med. There is also a type of buprenorphine that contains the ingredient naloxone, which is a med which blocks the effects of opioids. Someone consuming this version of the drug, also known as Suboxone, would find it harder to feel high from opioids if they relapsed while taking the drug. It is also taken every day, and costs about $450 /month. Naltrexone is another drug taken in opioid maintenance therapy, but unlike the other medications aforementioned it is an opiate blocker and isn't an opiate. There is an option to take this medication as a monthly injection, which is called Vivitrol. As an opioid blocker, the drug prevents an individual from getting high from opioids, and in turn lowers the risk associated with relapse. This daily injection costs in the range of $1000 to $1200 a month.
For All Drug and Alcohol Rehab Facilities In Sharon Hill, Click Here.
